Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
       
       
      NGS
        Improving Read 2 quality on Illumina NovaSeq X/X Plus PCR-free runs.
            August 28, 2025 -
            3 min read
          
          
         
      NGS
        Discordant mapping of R1 and R2 in WGS studies: understanding Illumina paired-end sequencing.
            August 28, 2025 -
            3 min read
          
          
         
      NGS
        Assessing error suppression strategies: a technical review of simplex and duplex UMIs.
            August 26, 2025 -
            4 min read
          
          
         
      Reproductive Health
        Closing the gap: how Revvity and Women’s Health Hub Finland are advancing women’s healthcare.
            August 25, 2025 -
            3 min read
          
          
         
       
      NGS
        Poly(A) selection vs rRNA depletion: guide for picking the right upstream method.
            August 25, 2025 -
            3 min read
          
          
         
      Reproductive Health
        Building tomorrow - the professional journey of an SMA scientist.
            August 25, 2025 -
            2 min read
          
          
         
      Neurodegeneration
        Validating brain-penetrating nanobodies with HTRF GPCR second messenger and receptor binding assays.
            August 20, 2025 -
            5 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  